Research Projects

Guidance on Passenger and Employee Health Screening In Reserve

In response to COVID19 but also inclusive of other contagions, airports need to understand how to plan, deploy and manage health screening.

Background (Describe the current situation or problem in the industry, and how your idea would address it.)

The United States is deeply engaged in fighting the COVID-19 Pandemic. The transportation industry is at the front line of this as the pandemic spreads from international ports of call to and through the United States. While we are specifically dealing with COVID19, pandemic threats are not new to the world or the aviation industry but the U.S. had been spared large impacts as compared to other parts of the world until now. Airports have parts and pieces of planning that began during the SARS, H1N1 and Ebola threats. Each of those tested wellness more for passengers as opposed to all airport and airline employee screening.

As the world deals with the new normal, quickly dealing with changing conditions have exposed several gaps as it pertains to airlines, airports and the general transportation sector in the U.S. While many airports and airlines have pandemic plans, the airport environment and those passing through it needs to have a specific focus for immediate planning and long term sustainability which needs to include health screening. Testing of travelling passengers, airline crews and employees in mass, in most cases, have not been adequately addressed. The industry needs to be prepared to deal with current conditions as well as future threats of pandemics or other serious health afflictions with high contagion factors.

Objective (What is the desired product or result that will help the airport industry?)

A guidebook should be developed to help airports plan for the best options to meet their specific needs. It needs to address airports of all size and complexity. To achieve this objective at a minimum the guidebook should include the following information:

a. Research on current practices for wellness screening plans in the aviation industry and other vulnerable industries like health care.

b. Types and methods for wellness screening including a best practices summary

c. Locations for wellness screening to be deployed

d. Technology for wellness screening

e. Processes and procedures for screening

f. How to ensure personal privacy and maintain compliance with "Health Insurance Portability and Accountability Act" of 1996 (HIPAA)

g. Airport and public information and training campaigns

h. Rough Order Magnitude of costs

i. Funding options

g. Road mapping/phased deployment

Approach (Describe in general terms the steps you think are needed to achieve the objective.)

Research

Case study interviews

Identify Best practices

Conduct beta tests for planning and deployment

Identify Technology solutions

Cost Estimate and Backup (Provide a cost estimate and support for how you arrived at the estimate.)

We will need team members with specific subject matter expertise including science technology and industry operations. Most best practices deployed have been international. That community should be involved in the study, therefore international travel for case studies should be considered. There should also be a couple U.S domestic beta airports involved in the study, representing small, medium and large which will also involve domestic travel, possibly two trips one for research and concept development and the other for the actual beta test deployment of some screening initiatives.

Related Research - List related ACRP and other industry research; describe gaps (see link to Research Roadmaps above), and describe how your idea would address these gaps. This is a critical element of a synthesis topic submission.

ACRP Report Conference Proceedings 47 "Research on the Transmission of Disease in Airports and on Aircraft (2010)

ACRP Report 91 "Infectious Disease Mitigation in Airports and on Aircraft" (2013)

Evans, A. D., and C. Thibeault. Prevention of Spread of

Communicable Disease by Air Travel. Aviation, Space,

and Environmental Medicine, Vol. 80, No. 7, 2009,

pp. 601–602. www.ingentaconnect.com/content/asma/

asem/2009/00000080/00000007/art00002.

Khan, K., J. Arino, F. Calderon, A. Chan, M. Gardam, C.

Heidebrecht, W. Hu, D. A. Janes, M. MacDonald, J. Sears,

P. Raposo, and S. Wang. An Analysis of Canada's Vulnerability

to Emerging Infectious Disease Threats via the

Global Airline Transportation Network. Bio.Diaspora,

Toronto, Ontario, Canada, 2009. www.biodiaspora.

com/.

Mangili, A., and M. A. Gendreau. Transmission of Infectious

Diseases During Commercial Air Travel. Lancet,

Vol. 365, 2005, pp. 989–996. www.ncbi.nlm.nih.gov/

pubmed/15767002?dopt=Abstract.

Silverman, D., and M. Gendreau. Medical Issues Associated

with Commercial Flights. Lancet, Vol. 373, 2009, pp.

2067–2077. www.thelancet.com/journals/lancet/article/

PIIS0140-6736(09)60209-9/fulltext.

Bitar, D., A. Goubar, and J. C. Desenclos. International Travels

and Fever Screening During Epidemics: A Literature

Review on the Effectiveness and Potential Use of Non-

Contact Infrared Thermometers. Eurosurveillance, Vol.

14, No. 6, 2009. www.eurosurveillance.org/ViewArticle.

aspx?ArticleId=19115.

Gaber, W., U. Goetsch, R. Diel, H. W. Doerr, and R.

Gottschalk. Screening for Infectious Diseases at International

Airports: The Frankfurt Model. Aviation, Space,

and Environmental Medicine, Vol. 80, No. 7, 2009,

pp. 595–600. www.ingentaconnect.com/content/asma/

asem/2009/00000080/00000007/art00001.

Annotations
Idea No. 426